Irlenbusch U, Schäller Th
Department of Orthopedic Surgery, Marienstift Arnstadt, Wachsenburgallee 12, D-99310 Arnstadt, Germany.
Osteoarthritis Cartilage. 2006 May;14(5):423-7. doi: 10.1016/j.joca.2005.11.016. Epub 2006 Jan 27.
Until the current molecular genetic investigations, all available data concerning the genetic predisposition to Heberden's nodes are based on a single investigation by Stecher in the 1940s. There is controversy in the literature about the correlation between Heberden's nodes and generalized osteoarthritis (GOA). Our own epidemiological and clinical investigations support this correlation. Therefore, the question arises as to whether the remarkable inheritance described by Stecher is correct and whether Heberden's nodes can indeed be used as a genetic marker for GOA.
From our clinical trial on 106 patients with Heberden's arthritis, we could identify 88 families from index cases. Altogether, we included 931 family members over a maximum of four generations. First of all, the genealogical trees of the families were established. Subsequently, we examined the patients' hands in respect of Heberden's nodes and completed the genealogical trees during home visits.
In the 88 families analyzed, 152 patients with manifest Heberden's arthritis were listed (26 males, 126 females). The genealogical analysis of 156 descendants (74 males, 82 females) of 93 patients with Heberden's nodes suggests autosomal dominant inheritance. In view of the age-related manifestation and age pattern of the descendants, we postulate a heterozygous manifestation for women (dominant gene action) and only a homozygous manifestation for men (recessive gene action).
The genealogic analysis does not contrast with the quite remarkable inheritance described by Stecher but rather supports the hypothesis that manifestation is dominant in females and recessive in males. From our point of view, this heredity does not contradict latest genetic assays which show the possibility of genetic defects causing the hereditary osteoarthritis (OA).
在当前的分子遗传学研究之前,所有关于赫伯登结节遗传易感性的可用数据都基于20世纪40年代斯特彻的一项单一研究。文献中关于赫伯登结节与全身性骨关节炎(GOA)之间的相关性存在争议。我们自己的流行病学和临床研究支持这种相关性。因此,问题在于斯特彻所描述的显著遗传模式是否正确,以及赫伯登结节是否确实可以用作GOA的遗传标记。
从我们对106例赫伯登关节炎患者的临床试验中,我们能够从索引病例中识别出88个家庭。总共,我们纳入了最多四代的931名家庭成员。首先,建立了这些家庭的系谱树。随后,我们检查了患者手部的赫伯登结节情况,并在家庭访视期间完善了系谱树。
在分析的88个家庭中,列出了152例患有明显赫伯登关节炎的患者(26名男性,126名女性)。对93例有赫伯登结节患者的156名后代(74名男性,82名女性)进行的系谱分析表明为常染色体显性遗传。鉴于后代的年龄相关表现和年龄模式,我们推测女性为杂合表现(显性基因作用),而男性仅为纯合表现(隐性基因作用)。
系谱分析与斯特彻所描述的相当显著的遗传模式并不矛盾,而是支持了女性表现为显性、男性表现为隐性的假说。在我们看来,这种遗传与最新的基因检测结果并不矛盾,后者显示了基因缺陷导致遗传性骨关节炎(OA)的可能性。